• REGADENOSON CHEMBL317052 FDA Approved

    Alternate Names:

    Regadenoson
    CVT-3146
    Lexiscan
    6-AMINO-2-[4-(METHYLCARBAMOYL)-1H-PYRAZOL-1-YL]PURINE-9-YL-BETA-D-RIBOFURANOSIDE;1-(6-AMINO-9-((2S,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)-TETRAHYDROFURAN-2-YLOXY)-9H-PURIN-2-YL)-N-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE
    1-[6-AMINO-9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL]PURIN-2-YL]-N-METHYL-PYRAZOLE-4-CARBOXAMIDE
    1-[6-AMINO-9-((2R,3R,4S,5R)-3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-9H-PURIN-2-YL]-1H-PYRAZOLE-4-CARBOXYLIC ACID METHYLAMIDE
    (1-(9-(3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL)-6-AMINOPURIN-2-YL)PYRAZOL-4-YL)-N-METHYLCARBOXAMIDE
    1-(6-AMINO-9-BETA-D-RIBOFURANOSYL-9H-PURIN-2-YL)-N-METHYL-1H-PYRAZOLE-4-CARBOXAMIDE
    ADENOSINE, 2-(4-((METHYLAMINO)CARBONYL)-1H-PYRAZOL-1-YL)-
    D05711
    FT-0674337
    CAS-313348-27-5
    LS-193008
    NU007666
    NU001889
    AT-36942
    NCGC00249892-01
    DB06213
    CV-3146
    ZINC13818943
    BDBM50119132
    AR-1D6945
    TOX21_113668
    AOB6869
    CTK4G6871
    GTPL5596
    AC1L55X1
    7AXV542LZ4
    SCHEMBL678893
    DSSTOX_GSID_57712
    DSSTOX_RID_97386
    DSSTOX_CID_31501
    AC1Q5LB1
    2-[4-[(METHYLAMINO)CARBONYL]-1H-PYRAZOL-1-YL]ADENOSINE
    REGADENOSON [USAN:INN]
    REGADENOSON (USAN/INN)
    LEXISCAN (TN)
    RAPISCAN
    RAPISCANREG
    LEXISCANREG
    1-[6-AMINO-9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]PURIN-2-YL]-N-METHYLPYRAZOLE-4-CARBOXAMIDE
    2-[4-(METHYLCARBAMOYL)-1H-PYRAZOL-1-YL]ADENOSINE
    CVT 3146
    UNII-7AXV542LZ4
    313348-27-5
    219024
    ADENOSINE,2-[4-[(METHYLAMINO)CARBONYL]-1H-PYRAZOL-1-YL]-
    Regadenoson anhydrous
    178102231
    5596

    Drug Info:

    FDA Approval approved
    Drug Class small molecule
    Drug Indications diagnostic agent
    Year of Approval 2008
    Drug Class vasodilator
    Drug Categories purinergic p1 receptor agonists
    Drug Categories purinergic agonists
    Drug Categories purinergic agents
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories neurotransmitter agents
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories chemical actions and uses
    Drug Categories cardiovascular system
    Drug Categories cardiac therapy
    Drug Categories azoles
    Drug Categories adenosine a2 receptor agonists
    Drug Groups approved
    Drug Type small molecule
    (2 More Sources)